Celcuity Inc. financial data

Symbol
CELC on Nasdaq
Industry
Services-Medical Laboratories
Location
16305 36 Th Avenue N, Suite 100, Minneapolis, MN
State of incorporation
DE
Fiscal year end
December 31
Former names
Celcuity LLC (to 9/15/2017)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.06K % -35.2%
Debt-to-equity 73.5 % +84.2%
Return On Equity -77.7 % -41.9%
Return On Assets -44.8 % -14.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.8M shares +24.3%
Common Stock, Shares, Outstanding 37.1M shares +45.6%
Entity Public Float 530M USD +177%
Common Stock, Value, Issued 37.1K USD +45.6%
Weighted Average Number of Shares Outstanding, Basic 39.4M shares +66.6%
Weighted Average Number of Shares Outstanding, Diluted 39.4M shares +66.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 104M USD +72%
General and Administrative Expense 9.06M USD +60.8%
Operating Income (Loss) -113M USD -71%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -112M USD -75.3%
Net Income (Loss) Attributable to Parent -112M USD -75.3%
Earnings Per Share, Basic -2.83 USD/shares -5.2%
Earnings Per Share, Diluted -2.83 USD/shares -5.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22.5M USD -26.6%
Other Assets, Current 9.47M USD -5.4%
Assets, Current 245M USD +28.3%
Property, Plant and Equipment, Net 337K USD +47.1%
Operating Lease, Right-of-Use Asset 216K USD -46.1%
Assets 245M USD +28.2%
Accounts Payable, Current 9.37M USD +84.5%
Accrued Liabilities, Current 22.2M USD +149%
Liabilities, Current 31.7M USD +124%
Operating Lease, Liability, Noncurrent 54K USD -76.1%
Liabilities 130M USD +152%
Retained Earnings (Accumulated Deficit) -272M USD -69.8%
Stockholders' Equity Attributable to Parent 116M USD -17.3%
Liabilities and Equity 245M USD +28.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.1M USD -32.6%
Net Cash Provided by (Used in) Financing Activities 14.1M USD +20627%
Net Cash Provided by (Used in) Investing Activities 3.54M USD -83.8%
Common Stock, Shares Authorized 95M shares +46.2%
Common Stock, Shares, Issued 37.1M shares +45.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 870K USD +16.5%
Deferred Tax Assets, Valuation Allowance 60.2M USD +66.6%
Operating Lease, Liability 226K USD -45%
Depreciation 29.6K USD -32.7%
Payments to Acquire Property, Plant, and Equipment 89.7K USD +1183%
Lessee, Operating Lease, Liability, to be Paid 295K USD -42%
Property, Plant and Equipment, Gross 2.33M USD +11.4%
Operating Lease, Liability, Current 172K USD -7.03%
Lessee, Operating Lease, Liability, to be Paid, Year Two 74.2K USD -66.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 220K USD +3.21%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 68.6K USD -29.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 74.2K USD
Deferred Tax Assets, Operating Loss Carryforwards 13.3M USD +57.7%
Preferred Stock, Shares Issued 318K shares -62.8%
Preferred Stock, Shares Authorized 2.5M shares 0%
Additional Paid in Capital 387M USD +29.2%
Preferred Stock, Shares Outstanding 318K shares -62.8%
Interest Expense 8.4M USD +82.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%